These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

598 related articles for article (PubMed ID: 30569229)

  • 1. Health-related quality of life in children with osteogenesis imperfecta: a large-sample study.
    Song Y; Zhao D; Li L; Lv F; Wang O; Jiang Y; Xia W; Xing X; Li M
    Osteoporos Int; 2019 Feb; 30(2):461-468. PubMed ID: 30569229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased fracture rate, pharmacogenetics and BMD response in 79 Swedish children with osteogenesis imperfecta types I, III and IV treated with Pamidronate.
    Lindahl K; Kindmark A; Rubin CJ; Malmgren B; Grigelioniene G; Söderhäll S; Ljunggren Ö; Åström E
    Bone; 2016 Jun; 87():11-8. PubMed ID: 26957348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship of Pathogenic Mutations and Responses to Zoledronic Acid in a Cohort of Osteogenesis Imperfecta Children.
    Sun L; Hu J; Liu J; Zhang Q; Wang O; Jiang Y; Xia W; Xing X; Li M
    J Clin Endocrinol Metab; 2022 Aug; 107(9):2571-2579. PubMed ID: 35727737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health-related quality of life of children and adolescents with osteogenesis imperfecta: a cross-sectional study using PedsQL™.
    Vanz AP; van de Sande Lee J; Pinheiro B; Zambrano M; Brizola E; da Rocha NS; Schwartz IVD; de Souza Pires MM; Félix TM
    BMC Pediatr; 2018 Mar; 18(1):95. PubMed ID: 29499676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health-Related Quality of Life in Adults with Osteogenesis Imperfecta.
    Hald JD; Folkestad L; Harsløf T; Brixen K; Langdahl B
    Calcif Tissue Int; 2017 Nov; 101(5):473-478. PubMed ID: 28676897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic epidemiology, prevalence, and genotype-phenotype correlations in the Swedish population with osteogenesis imperfecta.
    Lindahl K; Åström E; Rubin CJ; Grigelioniene G; Malmgren B; Ljunggren Ö; Kindmark A
    Eur J Hum Genet; 2015 Aug; 23(8):1042-50. PubMed ID: 25944380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive genetic analyses using targeted next-generation sequencing and genotype-phenotype correlations in 53 Japanese patients with osteogenesis imperfecta.
    Ohata Y; Takeyari S; Nakano Y; Kitaoka T; Nakayama H; Bizaoui V; Yamamoto K; Miyata K; Yamamoto K; Fujiwara M; Kubota T; Michigami T; Yamamoto K; Yamamoto T; Namba N; Ebina K; Yoshikawa H; Ozono K
    Osteoporos Int; 2019 Nov; 30(11):2333-2342. PubMed ID: 31363794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Skeletal phenotypes in adult patients with osteogenesis imperfecta-correlations with COL1A1/COL1A2 genotype and collagen structure.
    Hald JD; Folkestad L; Harsløf T; Lund AM; Duno M; Jensen JB; Neghabat S; Brixen K; Langdahl B
    Osteoporos Int; 2016 Nov; 27(11):3331-3341. PubMed ID: 27256333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genotype-phenotype relationship in a large cohort of osteogenesis imperfecta patients with COL1A1 mutations revealed by a new scoring system.
    Li LJ; Lyu F; Song YW; Wang O; Jiang Y; Xia WB; Xing XP; Li M
    Chin Med J (Engl); 2019 Jan; 132(2):145-153. PubMed ID: 30614853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene mutation spectrum and genotype-phenotype correlation in a cohort of Chinese osteogenesis imperfecta patients revealed by targeted next generation sequencing.
    Liu Y; Asan ; Ma D; Lv F; Xu X; Wang J; Xia W; Jiang Y; Wang O; Xing X; Yu W; Wang J; Sun J; Song L; Zhu Y; Yang H; Wang J; Li M
    Osteoporos Int; 2017 Oct; 28(10):2985-2995. PubMed ID: 28725987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mortality and morbidity in patients with osteogenesis imperfecta in Denmark.
    Folkestad L
    Dan Med J; 2018 Apr; 65(4):. PubMed ID: 29619932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A cross-sectional multicenter study of osteogenesis imperfecta in North America - results from the linked clinical research centers.
    Patel RM; Nagamani SC; Cuthbertson D; Campeau PM; Krischer JP; Shapiro JR; Steiner RD; Smith PA; Bober MB; Byers PH; Pepin M; Durigova M; Glorieux FH; Rauch F; Lee BH; Hart T; Sutton VR
    Clin Genet; 2015 Feb; 87(2):133-40. PubMed ID: 24754836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality of life of pediatric and adult individuals with osteogenesis imperfecta: a meta-analysis.
    Wehrli S; Rohrbach M; Landolt MA
    Orphanet J Rare Dis; 2023 May; 18(1):123. PubMed ID: 37226194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Responsiveness to pamidronate treatment is not related to the genotype of type I collagen in patients with osteogenesis imperfecta.
    Kanno J; Saito-Hakoda A; Kure S; Fujiwara I
    J Bone Miner Metab; 2018 May; 36(3):344-351. PubMed ID: 28528406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Genotypes and phenotypes of nine Uygur children with osteogenesis imperfecta in Xinjiang].
    Luo YF; Dilihuma J; Sun GH; Reyilanmu B; Liang L; Du XY; Mireguli M
    Zhonghua Er Ke Za Zhi; 2020 Feb; 58(2):135-139. PubMed ID: 32102151
    [No Abstract]   [Full Text] [Related]  

  • 16. Novel compound heterozygous mutations in SERPINH1 cause rare autosomal recessive osteogenesis imperfecta type X.
    Song Y; Zhao D; Xu X; Lv F; Li L; Jiang Y; Wang O; Xia W; Xing X; Li M
    Osteoporos Int; 2018 Jun; 29(6):1389-1396. PubMed ID: 29520608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of alendronate on quality of life in children with osteogenesis imperfecta.
    Seikaly MG; Kopanati S; Salhab N; Waber P; Patterson D; Browne R; Herring JA
    J Pediatr Orthop; 2005; 25(6):786-91. PubMed ID: 16294137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular abnormalities and its correlation with genotypes of children with osteogenesis imperfecta.
    Zhao D; Liu Y; Liu J; Hu J; Zhang Q; Wang O; Jiang Y; Xia W; Xing X; Li M
    Front Endocrinol (Lausanne); 2022; 13():1004946. PubMed ID: 36339400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pamidronate treatment of osteogenesis imperfecta--lack of correlation between clinical severity, age at onset of treatment, predicted collagen mutation and treatment response.
    Zacharin M; Bateman J
    J Pediatr Endocrinol Metab; 2002 Feb; 15(2):163-74. PubMed ID: 11874181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenotypic variability in patients with osteogenesis imperfecta caused by BMP1 mutations.
    Pollitt RC; Saraff V; Dalton A; Webb EA; Shaw NJ; Sobey GJ; Mughal MZ; Hobson E; Ali F; Bishop NJ; Arundel P; Högler W; Balasubramanian M
    Am J Med Genet A; 2016 Dec; 170(12):3150-3156. PubMed ID: 27576954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.